Thomas Darling

Thomas Darling, MD PhD, serves as Professor in the Dermatology Division of the Department of Medicine at the Uniformed Services University of the Health Sciences (USUHS) in Bethesda, Maryland. He has maintained this faculty position since 1999 following extensive clinical and research training, with expertise spanning regenerative dermatology, genetic skin disorders, and hamartoma syndromes. His work bridges laboratory science with clinical applications in wound healing and skin reconstruction.

His academic foundation includes:

• B.S. in Biology from Houghton College (1979-1983)
• MD-PhD from Duke University (1983-1990)
• Medicine Internship at UNC Hospitals (1990-1991)
• Dermatology Residency at Duke University Medical Center (1991-1994)
• Clinical Fellow at NIH Dermatology Branch (1994-1998)

Dr. Darling's research centers on skin regeneration mechanisms and hamartoma syndromes, particularly tuberous sclerosis complex (TSC). His laboratory pioneered human hair follicle neogenesis in dermal-epidermal composites, establishing foundational techniques for bioengineered skin substitutes. Current work focuses on developing next-generation skin replacements that regenerate functional appendages like hair follicles and sweat glands. His investigations integrate tissue engineering, molecular genetics, and dermatopathology to address critical limitations in current wound healing approaches.

Analysis of his 2023-2025 publications reveals converging expertise in genomic analysis of mosaic TSC disorders and advanced biomaterials for skin regeneration. His team increasingly employs next-generation sequencing to identify genetic markers in cutaneous manifestations while engineering peptide-enhanced composites to stimulate epidermal thickness and follicular neogenesis. This dual focus demonstrates a strategic trajectory from basic mechanistic studies toward clinically translatable regenerative therapies.

No specific scientific awards are documented in available records.

Dr. Darling has secured three major NIH-funded projects:

• National Cancer Institute: "Tumorigenesis in Tuberous Sclerosis" (2004-2009)
• National Cancer Institute: "Novel in vitro and xenograft models for tuberous sclerosis treatments" (2006-2009)
• National Institute of Arthritis and Musculoskeletal and Skin Diseases: "Regulation of Dermal Fibroblasts in Skin Regeneration" (2012-2015)

Mentoring activities are not detailed in current documentation, though his laboratory has produced 126 research outputs including significant contributions to TSC diagnostics and regenerative techniques.

His USU-based research laboratory maintains active collaborations with the National Cancer Institute, focusing on fibroblast regulation in wound healing and molecular pathways in lymphangioleiomyomatosis. The team employs xenograft models and dermal-epidermal composites to investigate mTOR signaling in hamartoma syndromes while developing clinically viable skin substitutes that regenerate functional microstructures essential for thermoregulation and barrier function.